UK Markets closed
  • NIKKEI 225

    27,131.34
    -457.06 (-1.66%)
     
  • HANG SENG

    24,243.61
    -412.89 (-1.67%)
     
  • CRUDE OIL

    85.15
    +1.84 (+2.21%)
     
  • GOLD FUTURES

    1,848.70
    +7.00 (+0.38%)
     
  • DOW

    34,297.73
    -66.77 (-0.19%)
     
  • BTC-GBP

    27,154.53
    -297.43 (-1.08%)
     
  • CMC Crypto 200

    833.18
    +22.57 (+2.78%)
     
  • Nasdaq

    13,539.29
    -229.61 (-1.67%)
     
  • ^FTAS

    4,139.47
    -77.84 (-1.85%)
     

GLOBAL JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030

·3-min read

KEY FINDINGS The global joint pain injections market is anticipated to register a CAGR of 8. 56% during the forecast years of 2022 to 2030. The market growth is attributable to key drivers such as the increased prevalence of bone and joint-related diseases across the geriatric population, the increasing number of sports injuries, and the rising incidence of musculoskeletal disorders.

New York, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030" - https://www.reportlinker.com/p06187333/?utm_source=GNW


MARKET INSIGHTS
Joint pain injections are medicinal fluids introduced into the patient’s body in order to facilitate faster relief from severe pain.They are utilized to reduce inflammation in the joints.

Several types of injections available in the market include corticosteroids injections, platelet-rich plasma (PRP) injections, hyaluronic acid (HA) injections, as well as placental tissue matrix (PTM) injections.
Musculoskeletal disorders (MSDs) entail medical conditions impacting muscles, bones, and joints of the shoulders, neck, wrists, hips, legs, back, knees, and feet.These diseases include tendinitis, osteoarthritis, carpal tunnel syndrome, rheumatoid arthritis (RA), bone fractures, and fibromyalgia.

According to the World Health Organization (WHO) factsheet updated in 2021, around 1.71 billion people have musculoskeletal conditions globally. Moreover, among musculoskeletal disorders, low back pain represents the highest burden, prevalent in approximately 568 million people. The high incidence of musculoskeletal disorders in different countries increases the number of treatment procedures conducted for the same, thus fueling the global joint pain injections market growth.

REGIONAL INSIGHTS
The global joint pain injections market growth evaluation comprises the assessment of Asia-Pacific, North America, Europe, and Rest of World.North America held the highest revenue share in 2021.

The region’s market growth is primarily facilitated by the augmenting demand for advanced therapeutic platforms to enhance treatment outcomes and the rising number of new product launches and approvals.

COMPETITIVE INSIGHTS
The competition among tier 1 companies as well as tier 2 and tier 3 companies in the global joint pain injections market is increasing.Moreover, the threat of rivalry is high among market players within their respective segments.

Vendors also differentiate their products on the basis of quality, cost, and application.
Some of the top firms operating in the market are Allergan PLC, Sanofi, Pfizer Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ALLERGAN PLC (ACQUIRED BY ABBVIE)
2. ANIKA THERAPEUTICS INC
3. BIOVENTUS INC
4. CHUGAI PHARMACEUTICAL
5. FERRING PHARMACEUTICALS
6. FIDIA PHARMA USA INC
7. FLEXION THERAPEUTICS INC
8. ORTHOGENRX INC
9. PFIZER INC
10. SANOFI
11. SEIKAGAKU CORPORATION
12. SMITH & NEPHEW PLC
13. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
14. ZIMMER BIOMET HOLDINGS
Read the full report: https://www.reportlinker.com/p06187333/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting